BiovistaBiovista Inc. is a private drug development services company based in Charlottesville, Virginia, US. Biovista's core business activities include drug repositioning and drug de-risking as well as disease cohort analysis, adverse event prediction and clinical hold analysis services. Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology.Biovista, Inc.Biovista, Inc.18713130997992069North America and EuropeCharlottesvilleAndreas PersidisAndreas PersidisAris PersidisCharlottesville, Virginia, US82200000.0Biovista Inc. is a private drug development services company based in Charlottesville, Virginia, US. Biovista's core business activities include drug repositioning and drug de-risking as well as disease cohort analysis, adverse event prediction and clinical hold analysis services. Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology. Biovista is an active participant of European Union co-funded R&D projects spanning areas such as post-genomic clinical trials research (ACGT project), mutant mouse models for the investigation of Human Immunological Disease (MUGEN project), semantic annotation and ontology driven text mining (PARMENIDES project) and systematic knowledge discovery (ESPERONTO Project).6141200582200000.0
